Benzinga's Top Downgrades
Analysts at Cantor Fitzgerald downgraded Endo Health Solutions (NASDAQ: ENDP) from “hold” to “sell.” The target price for Endo Health Solutions is set to $30. Endo Health's shares closed at $35.96 yesterday.
Analysts at Morgan Stanley downgraded First Horizon National (NYSE: FHN) from “overweight” to “neutral.” The target price for First Horizon National is set to $11. First Horizon National's shares closed at $11.25 yesterday.
Analysts at Piper Jaffray downgraded Vera Bradley (NASDAQ: VRA) from “overweight” to “neutral.” The price target for Vera Bradley has been lowered from $32 to $24. Vera Bradley's shares closed at $22.46 yesterday.
Berenberg downgraded Oracle (NASDAQ: ORCL) from “buy” to “sell.” The target price for Oracle has been lowered from $35 to $28. Oracle's shares closed at $34.12 yesterday.
Latest Ratings for ENDP
|Oct 2014||Cantor Fitzgerald||Upgrades||Sell||Hold|
|Sep 2014||RBC Capital||Initiates Coverage on||Outperform|
|Jul 2014||Cantor Fitzgerald||Maintains||Sell|
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.